Annual Debt To Equity
-2.46
-3.71-296.80%
30 September 2023
Summary:
Outlook Therapeutics annual debt to equity ratio is currently -2.46, with the most recent change of -3.71 (-296.80%) on 30 September 2023. During the last 3 years, it has fallen by -5.04 (-195.35%). OTLK annual debt to equity is now -179.10% below its all-time high of 3.11, reached on 30 September 2020.OTLK Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-0.39
-0.06-18.18%
30 June 2024
Summary:
Outlook Therapeutics quarterly debt to equity ratio is currently -0.39, with the most recent change of -0.06 (-18.18%) on 30 June 2024. Over the past year, it has increased by +2.07 (+84.15%). OTLK quarterly debt to equity is now -107.88% below its all-time high of 4.95, reached on 30 June 2016.OTLK Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +84.2% |
| 3 y3 years | -195.3% | -115.1% |
| 5 y5 years | -132.1% | +63.2% |
OTLK Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -195.3% | at low | -112.8% | +93.8% |
| 5 y | 5 years | -179.1% | at low | -112.5% | +93.8% |
| alltime | all time | -179.1% | at low | -107.9% | +95.4% |
Outlook Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -0.39(+18.2%) |
| Mar 2024 | - | -0.33(-78.0%) |
| Dec 2023 | - | -1.50(-39.0%) |
| Sept 2023 | -2.46(-296.8%) | -2.46(-61.0%) |
| June 2023 | - | -6.31(-307.6%) |
| Mar 2023 | - | 3.04(+50.5%) |
| Dec 2022 | - | 2.02(+61.6%) |
| Sept 2022 | 1.25(-51.6%) | 1.25(+140.4%) |
| June 2022 | - | 0.52(-18.8%) |
| Mar 2022 | - | 0.64(+39.1%) |
| Dec 2021 | - | 0.46(-82.2%) |
| Sept 2021 | 2.58(-17.0%) | 2.58(+180.4%) |
| June 2021 | - | 0.92(+67.3%) |
| Mar 2021 | - | 0.55(-150.9%) |
| Dec 2020 | - | -1.08(-134.7%) |
| Sept 2020 | 3.11 | 3.11(+284.0%) |
| June 2020 | - | 0.81(-190.0%) |
| Mar 2020 | - | -0.90(+57.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | - | -0.57(-46.2%) |
| Sept 2019 | -1.06(+23.3%) | -1.06(-87.4%) |
| June 2019 | - | -8.41(+1457.4%) |
| Mar 2019 | - | -0.54(-15.6%) |
| Dec 2018 | - | -0.64(-25.6%) |
| Sept 2018 | -0.86(+45.8%) | -0.86(-55.0%) |
| June 2018 | - | -1.91(+67.5%) |
| Mar 2018 | - | -1.14(-47.2%) |
| Dec 2017 | - | -2.16(+266.1%) |
| Sept 2017 | -0.59(-59.0%) | -0.59(+3.5%) |
| June 2017 | - | -0.57(+32.6%) |
| Mar 2017 | - | -0.43(-4.4%) |
| Dec 2016 | - | -0.45(-68.8%) |
| Sept 2016 | -1.44(+105.7%) | -1.44(-129.1%) |
| June 2016 | - | 4.95(-885.7%) |
| Mar 2016 | - | -0.63(-44.2%) |
| Dec 2015 | - | -1.13(+61.4%) |
| Sept 2015 | -0.70(0.0%) | -0.70 |
| Sept 2014 | -0.70 | - |
FAQ
- What is Outlook Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly debt to equity year-on-year change?
What is Outlook Therapeutics annual debt to equity ratio?
The current annual debt to equity of OTLK is -2.46
What is the all time high annual debt to equity for Outlook Therapeutics?
Outlook Therapeutics all-time high annual debt to equity ratio is 3.11
What is Outlook Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of OTLK is -0.39
What is the all time high quarterly debt to equity for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly debt to equity ratio is 4.95
What is Outlook Therapeutics quarterly debt to equity year-on-year change?
Over the past year, OTLK quarterly debt to equity ratio has changed by +2.07 (+84.15%)